Heart Sisters

DECEMBER 29, 2024

Was this particular article the most popular of 2024 because my HEART SISTERS readers aren't getting clear jargon-free, patient-friendly answers from their doctors?

Article 108

Article 108

HCPLive

JANUARY 8, 2025

This Month in Review captures 7 sleep medicine news, including FDA updates, from December 2024.

105

105

HCPLive

OCTOBER 27, 2024

Hiddo Heerspink, PhD, PharmD, joins the podcast during Kidney Week 2024 to discuss the SMART trial and the potential of semaglutide in people with kidney disease without diabetes.

Kidney Disease 133

Kidney Disease Diabetes 133

HCPLive

DECEMBER 16, 2024

In this episode, hosts reflect on the advancement in CGM that reshaped care for diabetes and overall health during 2024.

Diabetes 115

Diabetes 115

HCPLive

DECEMBER 27, 2024

2024 was a historic year in hepatology, characterized by notable hepatic FDA approvals, pipeline developments, new WHO HBV guidelines, and more.

98

98

HCPLive

JULY 29, 2024

A recap of the 5 most popular topics related to gene therapy in ophthalmology coming from the 42nd American Society of Retina Specialists meeting.

138

138

HCPLive

DECEMBER 26, 2024

From groundbreaking therapies to ethical dilemmas, HCPLives top podcasts of 2024 delivered expert insights and human stories across medicine.

108

108

Med Page Today

DECEMBER 31, 2024

(MedPage Today) -- MedPage Today's enterprise and investigative team covers a lot of ground. We jump in when there's breaking news in healthcare. We write second-day stories on the implications of that news. We craft compelling feature stories.

116

116

DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting. “We

Innovation 105

Innovation Coronary Artery Disease Hospital Cardiovascular Disease 105

DAIC

JULY 9, 2024

The American Heart Association, commemorating its 100th year, has announced its volunteer leadership for fiscal year 2024-2025, which includes Keith Churchwell, MD, FAHA, a cardiologist renowned as a health equity champion, and Marsha Jones, an executive leader in workplace diversity and inclusion. Keith Churchwell, M.D.,

Innovation 111

Innovation Health Disparities Cardiovascular Disease Medicaid 111

DAIC

JULY 30, 2024

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept. On Thursday, Sept.

Heart Rhythm 105

Heart Rhythm Innovation Technology Education 105

HCPLive

OCTOBER 4, 2024

This episode focuses on 5 key updates from Maui Derm NP+PA Fall 2024 in Nashville. Counting down the most impactful news at major medical meetings, it’s the HCPLive Five!

98

98

HCPLive

OCTOBER 23, 2024

Jonathan Barratt, PhD, discusses his excitement surrounding data and programming at the American Society of Nephrology's Kidney Week 2024, with a focus on IgAN.

105

105

HCPLive

NOVEMBER 10, 2024

PEDFIC data at NASPGHAN 2024 show mild, transient diarrhea events with odevixibat for cholestatic pruritus in PFIC, resolving in most cases.

Pediatrics 98

Pediatrics 98

HCPLive

DECEMBER 9, 2024

In this month's episode of Lungcast, Jacob Sands, MD, discusses the American Lung Associations recently newly-released 2024 State of Lung Cancer report.

Cancer 105

Cancer 105

HCPLive

DECEMBER 3, 2024

An overview and landing page for future installments from HCPLive's 8th annual This Year in Medicine Series.

123

123

HCPLive

OCTOBER 4, 2024

A review of 5 highly anticipated FDA decisions expected by year-end, including acoramidis for ATTR-CM, olezarsen for FCS, sotagliflozin for T1D and CKD, and more.

116

116

Heart Sisters

FEBRUARY 18, 2024

Don’t miss this Heart Month interview about women’s heart health that I did with pharmacist/science communicator Lindsay Dixon!

Risk Factors 127

Risk Factors Heart Disease 127

HCPLive

JANUARY 3, 2025

This Psychiatry Month in Review features promising phase 3 data, what is moving in the pipeline, and where the psychiatry field is heading into 2025.

105

105

ECG Weekly Workout

DECEMBER 31, 2023

HPI: A 50-year-old man decides to get “his life in order” for the new year. He quits smoking, decides to eat healthier and exercise more, and to be more compliant with his blood pressure medications. A week into the new year he wakes up feeling weak and achy with nausea and vomiting.

Blood Pressure 130

Blood Pressure CME Exercise Bradycardia 130

Med Page Today

DECEMBER 28, 2024

(MedPage Today) -- In January, we reported on the FDA clearing GLP-1 receptor agonists of suicidality risk following a preliminary evaluation. In this report, we follow up on what has happened since. Not long after the FDA wrapped its preliminary.

122

122

HCPLive

DECEMBER 16, 2024

Needle-free treatments, such as Neffy and FluMist, offer promising alternatives for children and adults with needle phobia, ensuring access to critical care.

Critical Care 97

Critical Care 97

Dr. Smith's ECG Blog

NOVEMBER 27, 2024

3) We do not show the upward concavity measurement technique here. == MY Comment , by K EN G RAUER, MD ( 11/27 /2024 ): == For optimally time-efficient identification of acute OMI in the absence of frank ST elevation — it's essential to get good at recognizing hyperacute T waves. "A A picture is worth 1,000 words".

Blog 132

Blog STEMI Research Outcomes 132

DAIC

NOVEMBER 18, 2024

tim.hodson Mon, 11/18/2024 - 10:55 Nov.

Peripheral Arterial Disease 98

Peripheral Arterial Disease Blood Clot Coronary Artery Disease General Cardiology 98

Nature Reviews - Cardiology

NOVEMBER 18, 2024

Nature Reviews Cardiology, Published online: 19 November 2024; doi:10.1038/s41569-024-01105-y Large language models represent a transformative leap in artificial intelligence and natural language processing, offering exciting potential across cardiology, from clinical care to education and research.

Education 75

Education Research 75

American Heart News - Heart News

JUNE 4, 2024

ET Tuesday, June 4, 2024 DALLAS, June 4, 2024 — Driven by an older, more diverse population, along with a significant increase in risk factors including high blood pressure and obesity, total costs related to. Embargoed until 4 a.m.

Risk Factors 143

Risk Factors Cardiovascular Disease Blood Pressure Obesity 143

DAIC

MARCH 14, 2025

In 2024, over 4,500 heart transplants were performed in the U.S. 8 Additionally, in 2024 more than 700 patients received an SPK transplant. 2024 May;28(3):e14705. 2024 Oct;38(10):e15481. Woodward, CareDx Chief Scientific Officer. with about 10 percent under the age of 18. Pediatr Transplant. doi: 10.1111/petr.14705.

Heart Transplant 87

Heart Transplant Transplant Pediatrics Quality of Life 87

American Heart News - Stroke News

FEBRUARY 6, 2024

6, 2024 PHOENIX, Feb. 6, 2024 – Eleven scientists leading the way in stroke research will be recognized during the American Stroke Association’s International Stroke Conference 2024 for their. Embargoed until 8 a.m. ET, Tuesday, Feb.

Strokes 134

Strokes Stroke Research 134

Heart BMJ

MARCH 26, 2025

Methods We systematically searched PubMed/MEDLINE, EMBASE and Cochrane CENTRAL from inception to 22 January 2024. We performed this network meta-analysis to identify the most effective and safest preventions and treatments for pericardial complications following cardiac surgery. Pairs of reviewers screened eligible studies.

Open-Heart Surgery 85

Open-Heart Surgery Pharmacology Atrial Fibrillation Pericarditis 85

American College of Cardiology

NOVEMBER 1, 2024

Of note, the 2025 PFS conversion factor is $32.3465, a reduction of 2.83% from $33.2875 in 2024. Overall, PFS reimbursement for cardiovascular services is projected to remain flat compared with 2024, with changes to policies and individual services roughly balancing out.

CMS 60

CMS Medicare Hospital Reimbursement 60

HCPLive

MARCH 7, 2024

On March 07, 2024, Boehringer Ingelheim announced it would be instituting a $35 per month out-of-pocket cost cap for its portfolio of inhaler products, with this cap going into effect on June 01, 2024.

140

140

American Heart News - Heart News

FEBRUARY 12, 2024

12, 2024 DALLAS, Feb. 12, 2024 — Dramatic advances in the understanding and treatment of cardiovascular diseases have saved millions of lives in the 100 years since the founding in 1924 of the American. Embargoed until 4 a.m. ET Monday, Feb.

Cardiovascular Disease 138

Cardiovascular Disease 138

HCPLive

JULY 31, 2024

Trust in physicians and hospitals dropped from over 70% in 2020 to under 50% in 2024, with declines seen across all demographics, a new survey shows.

COVID-19 140

COVID-19 Hospital 140

American College of Cardiology

OCTOBER 30, 2024

Results from the FLASH trial demonstrate the noninferiority of artificial intelligence-based fully automated quantitative coronary angiography (AI-QCA)-assisted PCI compared with optical coherence tomography (OCT)-guided PCI in achieving optimal minimal stent area, with comparable procedural complications, OCT-defined endpoints, and six-month clinical (..)

Stents 53

Stents Stent Research Outcomes 53

HCPLive

MARCH 20, 2024

announced the FDA's approval of aprocitentan (Tryvio) for treatment-resistant hypertension on March 20, 2024. Idorsia Ltd.

Hypertension 145

Hypertension 145

Nature Reviews - Cardiology

JULY 16, 2024

Nature Reviews Cardiology, Published online: 17 July 2024; doi:10.1038/s41569-024-01061-7 Various dietary patterns have been proposed to improve cardiometabolic health. In this Review, Pagidipati et al.

Diet 144

Diet Hypertension 144

Nature Reviews - Cardiology

AUGUST 6, 2024

Nature Reviews Cardiology, Published online: 07 August 2024; doi:10.1038/s41569-024-01064-4 In this Review, Ghofrani and colleagues discuss the mechanisms underlying the development of pulmonary arterial hypertension, provide an overview of approved therapies and describe the predominantly non-vasodilatory drugs that are currently being tested in clinical (..)

Pulmonary 140

Pulmonary Hypertension 140